APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Cas12 Nuclease

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Cas12 Nuclease Industry Growth and Trends Forecast to 2032

Report ID 173975320128 December 2025107 pages

Choose your research edition.

Industry ResearchCas12 Nuclease Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Cas12 Nuclease Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Cas12 Nuclease Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cas12 Nuclease Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Cas12 Nuclease Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Cas12 Nuclease market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Cas12 Nuclease is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Cas12 Nuclease is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cas12 Nuclease is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Cas12 Nuclease include Yeasen Biotechnology, Beyotime Biotech, Synthego, Signalchem, Sigma-Aldrich, New England Biolabs, Molecular Cloning Laboratories, Integrated DNA Technologies and Intact Genomics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Cas12 Nuclease market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Cas12 Nuclease market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Cas12 Nuclease market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Cas12 Nuclease.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Cas12 Nuclease market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Cas12 Nuclease Market by Company

Yeasen Biotechnology

Beyotime Biotech

Synthego

Signalchem

Sigma-Aldrich

New England Biolabs

Molecular Cloning Laboratories

Integrated DNA Technologies

Intact Genomics

GenScript

Danaher

BPS Bioscience

Cas12 Nuclease Segment by Type

Cas12a

Cas12b

Other

Cas12 Nuclease Segment by Application

Biopharmaceutical

Academic & Research Institutes

Hospitals & Diagnostic Centers

Other

Cas12 Nuclease Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cas12 Nuclease market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cas12 Nuclease and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cas12 Nuclease.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Cas12 Nuclease manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Cas12 Nuclease in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Cas12a Table 2. Major Company of Cas12b Table 3. Major Company of Other Table 4. Global Cas12 Nuclease Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Cas12 Nuclease Sales by Type (2021-2026) & (K Units) Table 6. Global Cas12 Nuclease Sales Market Share in Volume by Type (2021-2026) Table 7. Global Cas12 Nuclease Sales by Type (2021-2026) & (US$ Million) Table 8. Global Cas12 Nuclease Sales Market Share in Value by Type (2021-2026) Table 9. Global Cas12 Nuclease Price by Type (2021-2026) & (US$/Unit) Table 10. Global Cas12 Nuclease Sales by Type (2027-2032) & (K Units) Table 11. Global Cas12 Nuclease Sales Market Share in Volume by Type (2027-2032) Table 12. Global Cas12 Nuclease Sales by Type (2027-2032) & (US$ Million) Table 13. Global Cas12 Nuclease Sales Market Share in Value by Type (2027-2032) Table 14. Global Cas12 Nuclease Price by Type (2027-2032) & (US$/Unit) Table 15. North America Cas12 Nuclease Sales by Type (2021-2026) & (K Units) Table 16. North America Cas12 Nuclease Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Cas12 Nuclease Sales by Type (2021-2026) & (K Units) Table 18. Europe Cas12 Nuclease Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Cas12 Nuclease Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Cas12 Nuclease Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Cas12 Nuclease Sales by Type (2021-2026) & (K Units) Table 22. Latin America Cas12 Nuclease Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Cas12 Nuclease Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Cas12 Nuclease Sales by Type (2021-2026) & (US$ Million) Table 25. Cas12 Nuclease Industry Trends Table 26. Cas12 Nuclease Industry Drivers Table 27. Cas12 Nuclease Industry Opportunities and Challenges Table 28. Cas12 Nuclease Industry Restraints Table 29. Global Cas12 Nuclease Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Cas12 Nuclease Revenue Market Share by Company (2021-2026) Table 31. Global Cas12 Nuclease Sales by Company (2021-2026) & (K Units) Table 32. Global Cas12 Nuclease Sales Share by Company (2021-2026) Table 33. Global Cas12 Nuclease Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Cas12 Nuclease Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Cas12 Nuclease Major Company Production Sites and Headquarters Table 36. Global Cas12 Nuclease Company, Product Type & Application Table 37. Global Cas12 Nuclease Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Cas12 Nuclease by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Cas12 Nuclease Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Cas12 Nuclease Sales by Region (2021-2026) & (K Units) Table 42. Global Cas12 Nuclease Sales Market Share in Volume by Region (2021-2026) Table 43. Global Cas12 Nuclease Sales by Region (2021-2026) & (US$ Million) Table 44. Global Cas12 Nuclease Sales Market Share in Value by Region (2021-2026) Table 45. Global Cas12 Nuclease Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Cas12 Nuclease Sales by Region (2027-2032) & (K Units) Table 47. Global Cas12 Nuclease Sales Market Share in Volume by Region (2027-2032) Table 48. Global Cas12 Nuclease Sales by Region (2027-2032) & (US$ Million) Table 49. Global Cas12 Nuclease Sales Market Share in Value by Region (2027-2032) Table 50. Global Cas12 Nuclease Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Cas12 Nuclease Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Cas12 Nuclease Sales by Application (2021-2026) & (K Units) Table 53. Global Cas12 Nuclease Sales Market Share in Volume by Application (2021-2026) Table 54. Global Cas12 Nuclease Sales by Application (2021-2026) & (US$ Million) Table 55. Global Cas12 Nuclease Sales Market Share in Value by Application (2021-2026) Table 56. Global Cas12 Nuclease Price by Application (2021-2026) & (US$/Unit) Table 57. Global Cas12 Nuclease Sales by Application (2027-2032) & (K Units) Table 58. Global Cas12 Nuclease Sales Market Share in Volume by Application (2027-2032) Table 59. Global Cas12 Nuclease Sales by Application (2027-2032) & (US$ Million) Table 60. Global Cas12 Nuclease Sales Market Share in Value by Application (2027-2032) Table 61. Global Cas12 Nuclease Price by Application (2027-2032) & (US$/Unit) Table 62. North America Cas12 Nuclease Sales by Application (2021-2026) & (K Units) Table 63. North America Cas12 Nuclease Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Cas12 Nuclease Sales by Application (2021-2026) & (K Units) Table 65. Europe Cas12 Nuclease Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Cas12 Nuclease Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Cas12 Nuclease Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Cas12 Nuclease Sales by Application (2021-2026) & (K Units) Table 69. Latin America Cas12 Nuclease Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Cas12 Nuclease Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Cas12 Nuclease Sales by Application (2021-2026) & (US$ Million) Table 72. Yeasen Biotechnology Company Information Table 73. Yeasen Biotechnology Business Overview Table 74. Yeasen Biotechnology Cas12 Nuclease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Yeasen Biotechnology Cas12 Nuclease Product Portfolio Table 76. Yeasen Biotechnology Recent Development Table 77. Beyotime Biotech Company Information Table 78. Beyotime Biotech Business Overview Table 79. Beyotime Biotech Cas12 Nuclease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Beyotime Biotech Cas12 Nuclease Product Portfolio Table 81. Beyotime Biotech Recent Development Table 82. Synthego Company Information Table 83. Synthego Business Overview Table 84. Synthego Cas12 Nuclease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Synthego Cas12 Nuclease Product Portfolio Table 86. Synthego Recent Development Table 87. Signalchem Company Information Table 88. Signalchem Business Overview Table 89. Signalchem Cas12 Nuclease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Signalchem Cas12 Nuclease Product Portfolio Table 91. Signalchem Recent Development Table 92. Sigma-Aldrich Company Information Table 93. Sigma-Aldrich Business Overview Table 94. Sigma-Aldrich Cas12 Nuclease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Sigma-Aldrich Cas12 Nuclease Product Portfolio Table 96. Sigma-Aldrich Recent Development Table 97. New England Biolabs Company Information Table 98. New England Biolabs Business Overview Table 99. New England Biolabs Cas12 Nuclease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. New England Biolabs Cas12 Nuclease Product Portfolio Table 101. New England Biolabs Recent Development Table 102. Molecular Cloning Laboratories Company Information Table 103. Molecular Cloning Laboratories Business Overview Table 104. Molecular Cloning Laboratories Cas12 Nuclease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Molecular Cloning Laboratories Cas12 Nuclease Product Portfolio Table 106. Molecular Cloning Laboratories Recent Development Table 107. Integrated DNA Technologies Company Information Table 108. Integrated DNA Technologies Business Overview Table 109. Integrated DNA Technologies Cas12 Nuclease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Integrated DNA Technologies Cas12 Nuclease Product Portfolio Table 111. Integrated DNA Technologies Recent Development Table 112. Intact Genomics Company Information Table 113. Intact Genomics Business Overview Table 114. Intact Genomics Cas12 Nuclease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Intact Genomics Cas12 Nuclease Product Portfolio Table 116. Intact Genomics Recent Development Table 117. GenScript Company Information Table 118. GenScript Business Overview Table 119. GenScript Cas12 Nuclease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. GenScript Cas12 Nuclease Product Portfolio Table 121. GenScript Recent Development Table 122. Danaher Company Information Table 123. Danaher Business Overview Table 124. Danaher Cas12 Nuclease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Danaher Cas12 Nuclease Product Portfolio Table 126. Danaher Recent Development Table 127. BPS Bioscience Company Information Table 128. BPS Bioscience Business Overview Table 129. BPS Bioscience Cas12 Nuclease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. BPS Bioscience Cas12 Nuclease Product Portfolio Table 131. BPS Bioscience Recent Development Table 132. North America Cas12 Nuclease Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 133. North America Cas12 Nuclease Sales by Country (2021-2026) & (K Units) Table 134. North America Cas12 Nuclease Sales Market Share by Country (2021-2026) Table 135. North America Cas12 Nuclease Sales Forecast by Country (2027-2032) & (K Units) Table 136. North America Cas12 Nuclease Sales Market Share Forecast by Country (2027-2032) Table 137. North America Cas12 Nuclease Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 138. North America Cas12 Nuclease Market Size by Country (2021-2026) & (US$ Million) Table 139. North America Cas12 Nuclease Market Share by Country (2021-2026) Table 140. North America Cas12 Nuclease Market Size Forecast by Country (2027-2032) & (US$ Million) Table 141. North America Cas12 Nuclease Market Share Forecast by Country (2027-2032) Table 142. Europe Cas12 Nuclease Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 143. Europe Cas12 Nuclease Sales by Country (2021-2026) & (K Units) Table 144. Europe Cas12 Nuclease Sales Market Share by Country (2021-2026) Table 145. Europe Cas12 Nuclease Sales Forecast by Country (2027-2032) & (K Units) Table 146. Europe Cas12 Nuclease Sales Market Share Forecast by Country (2027-2032) Table 147. Europe Cas12 Nuclease Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. Europe Cas12 Nuclease Market Size by Country (2021-2026) & (US$ Million) Table 149. Europe Cas12 Nuclease Market Share by Country (2021-2026) Table 150. Europe Cas12 Nuclease Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. Europe Cas12 Nuclease Market Share Forecast by Country (2027-2032) Table 152. Asia-Pacific Cas12 Nuclease Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 153. Asia-Pacific Cas12 Nuclease Sales by Country (2021-2026) & (K Units) Table 154. Asia-Pacific Cas12 Nuclease Sales Market Share by Country (2021-2026) Table 155. Asia-Pacific Cas12 Nuclease Sales Forecast by Country (2027-2032) & (K Units) Table 156. Asia-Pacific Cas12 Nuclease Sales Market Share Forecast by Country (2027-2032) Table 157. Asia-Pacific Cas12 Nuclease Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. Asia-Pacific Cas12 Nuclease Market Size by Country (2021-2026) & (US$ Million) Table 159. Asia-Pacific Cas12 Nuclease Market Share by Country (2021-2026) Table 160. Asia-Pacific Cas12 Nuclease Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. Asia-Pacific Cas12 Nuclease Market Share Forecast by Country (2027-2032) Table 162. Latin America Cas12 Nuclease Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 163. Latin America Cas12 Nuclease Sales by Country (2021-2026) & (K Units) Table 164. Latin America Cas12 Nuclease Sales Market Share by Country (2021-2026) Table 165. Latin America Cas12 Nuclease Sales Forecast by Country (2027-2032) & (K Units) Table 166. Latin America Cas12 Nuclease Sales Market Share Forecast by Country (2027-2032) Table 167. Latin America Cas12 Nuclease Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 168. Latin America Cas12 Nuclease Market Size by Country (2021-2026) & (US$ Million) Table 169. Latin America Cas12 Nuclease Market Share by Country (2021-2026) Table 170. Latin America Cas12 Nuclease Market Size Forecast by Country (2027-2032) & (US$ Million) Table 171. Latin America Cas12 Nuclease Market Share Forecast by Country (2027-2032) Table 172. Middle East and Africa Cas12 Nuclease Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 173. Middle East and Africa Cas12 Nuclease Sales by Country (2021-2026) & (K Units) Table 174. Middle East and Africa Cas12 Nuclease Sales Market Share by Country (2021-2026) Table 175. Middle East and Africa Cas12 Nuclease Sales Forecast by Country (2027-2032) & (K Units) Table 176. Middle East and Africa Cas12 Nuclease Sales Market Share Forecast by Country (2027-2032) Table 177. Middle East and Africa Cas12 Nuclease Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 178. Middle East and Africa Cas12 Nuclease Market Size by Country (2021-2026) & (US$ Million) Table 179. Middle East and Africa Cas12 Nuclease Market Share by Country (2021-2026) Table 180. Middle East and Africa Cas12 Nuclease Market Size Forecast by Country (2027-2032) & (US$ Million) Table 181. Middle East and Africa Cas12 Nuclease Market Share Forecast by Country (2027-2032) Table 182. Key Raw Materials Table 183. Raw Materials Key Suppliers Table 184. Cas12 Nuclease Distributors List Table 185. Cas12 Nuclease Customers List Table 186. Research Programs/Design for This Report Table 187. Authors List of This Report Table 188. Secondary Sources Table 189. Primary Sources List of Figures Figure 1. Cas12 Nuclease Image Figure 2. Global Cas12 Nuclease Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cas12 Nuclease Market Size (2021-2032) & (US$ Million) Figure 4. Global Cas12 Nuclease Sales (2021-2032) & (K Units) Figure 5. Cas12a Image Figure 6. Global Cas12a Sales YoY Growth (2021-2032) & (K Units) Figure 7. Cas12b Image Figure 8. Global Cas12b Sales YoY Growth (2021-2032) & (K Units) Figure 9. Other Image Figure 10. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Cas12 Nuclease Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Cas12 Nuclease Market Share by Type 2025 VS 2032 Figure 13. North America Cas12 Nuclease Sales Market Share in Volume by Type in 2025 Figure 14. North America Cas12 Nuclease Sales Market Share in Value by Type in 2025 Figure 15. Europe Cas12 Nuclease Sales Market Share in Volume by Type in 2025 Figure 16. Europe Cas12 Nuclease Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Cas12 Nuclease Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Cas12 Nuclease Sales Market Share in Value by Type in 2025 Figure 19. Latin America Cas12 Nuclease Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Cas12 Nuclease Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Cas12 Nuclease Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Cas12 Nuclease Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Cas12 Nuclease Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Biopharmaceutical Image Figure 26. Global Biopharmaceutical Sales YoY Growth (2021-2032) & (K Units) Figure 27. Academic & Research Institutes Image Figure 28. Global Academic & Research Institutes Sales YoY Growth (2021-2032) & (K Units) Figure 29. Hospitals & Diagnostic Centers Image Figure 30. Global Hospitals & Diagnostic Centers Sales YoY Growth (2021-2032) & (K Units) Figure 31. Other Image Figure 32. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 33. Global Cas12 Nuclease Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Cas12 Nuclease Market Share by Application 2025 VS 2032 Figure 35. North America Cas12 Nuclease Sales Market Share in Volume by Application in 2025 Figure 36. North America Cas12 Nuclease Sales Market Share in Value by Application in 2025 Figure 37. Europe Cas12 Nuclease Sales Market Share in Volume by Application in 2025 Figure 38. Europe Cas12 Nuclease Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Cas12 Nuclease Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Cas12 Nuclease Sales Market Share in Value by Application in 2025 Figure 41. Latin America Cas12 Nuclease Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Cas12 Nuclease Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Cas12 Nuclease Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Cas12 Nuclease Sales Market Share in Value by Application in 2025 Figure 45. North America Cas12 Nuclease Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. North America Cas12 Nuclease Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Cas12 Nuclease Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Cas12 Nuclease Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Cas12 Nuclease Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Europe Cas12 Nuclease Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Cas12 Nuclease Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Cas12 Nuclease Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Cas12 Nuclease Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Asia-Pacific Cas12 Nuclease Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Cas12 Nuclease Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Cas12 Nuclease Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Cas12 Nuclease Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Latin America Cas12 Nuclease Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Cas12 Nuclease Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Cas12 Nuclease Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Cas12 Nuclease Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Middle East and Africa Cas12 Nuclease Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Cas12 Nuclease Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Cas12 Nuclease Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Cas12 Nuclease Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Cas12 Nuclease Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Cas12a
  • Cas12b
  • Other
Applications
  • Biopharmaceutical
  • Academic & Research Institutes
  • Hospitals & Diagnostic Centers
  • Other
Companies covered
  • Yeasen Biotechnology
  • Beyotime Biotech
  • Synthego
  • Signalchem
  • Sigma-Aldrich
  • New England Biolabs
  • Molecular Cloning Laboratories
  • Integrated DNA Technologies
  • Intact Genomics
  • GenScript
  • Danaher
  • BPS Bioscience

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Cas12 Nuclease Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Cas12 Nuclease Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Cas12 Nuclease Market by Type
  6. 1.3.1 Cas12a
  7. 1.3.2 Cas12b
  8. 1.3.3 Other
  9. 1.4 Global Cas12 Nuclease Market Size by Type
  10. 1.4.1 Global Cas12 Nuclease Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Cas12 Nuclease Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Cas12 Nuclease Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Cas12 Nuclease Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Cas12 Nuclease Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Cas12 Nuclease Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Cas12 Nuclease Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Cas12 Nuclease Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Cas12 Nuclease Industry Trends
  2. 2.2 Cas12 Nuclease Industry Drivers
  3. 2.3 Cas12 Nuclease Industry Opportunities and Challenges
  4. 2.4 Cas12 Nuclease Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Cas12 Nuclease Revenue (2021-2026)
  2. 3.2 Global Top Players by Cas12 Nuclease Sales (2021-2026)
  3. 3.3 Global Top Players by Cas12 Nuclease Price (2021-2026)
  4. 3.4 Global Cas12 Nuclease Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Cas12 Nuclease Major Company Production Sites & Headquarters
  6. 3.6 Global Cas12 Nuclease Company, Product Type & Application
  7. 3.7 Global Cas12 Nuclease Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Cas12 Nuclease Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Cas12 Nuclease Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Cas12 Nuclease Tier 1, Tier 2, and Tier 3
4 Cas12 Nuclease Regional Status and Outlook
  1. 4.1 Global Cas12 Nuclease Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Cas12 Nuclease Historic Market Size by Region
  3. 4.2.1 Global Cas12 Nuclease Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Cas12 Nuclease Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Cas12 Nuclease Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Cas12 Nuclease Forecasted Market Size by Region
  7. 4.3.1 Global Cas12 Nuclease Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Cas12 Nuclease Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Cas12 Nuclease Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Cas12 Nuclease by Application
  1. 5.1 Cas12 Nuclease Market by Application
  2. 5.1.1 Biopharmaceutical
  3. 5.1.2 Academic & Research Institutes
  4. 5.1.3 Hospitals & Diagnostic Centers
  5. 5.1.4 Other
  6. 5.2 Global Cas12 Nuclease Market Size by Application
  7. 5.2.1 Global Cas12 Nuclease Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Cas12 Nuclease Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Cas12 Nuclease Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Cas12 Nuclease Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Cas12 Nuclease Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Cas12 Nuclease Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Cas12 Nuclease Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Cas12 Nuclease Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Yeasen Biotechnology
  2. 6.1.1 Yeasen Biotechnology Company Information
  3. 6.1.2 Yeasen Biotechnology Business Overview
  4. 6.1.3 Yeasen Biotechnology Cas12 Nuclease Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Yeasen Biotechnology Cas12 Nuclease Product Portfolio
  6. 6.1.5 Yeasen Biotechnology Recent Developments
  7. 6.2 Beyotime Biotech
  8. 6.2.1 Beyotime Biotech Company Information
  9. 6.2.2 Beyotime Biotech Business Overview
  10. 6.2.3 Beyotime Biotech Cas12 Nuclease Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Beyotime Biotech Cas12 Nuclease Product Portfolio
  12. 6.2.5 Beyotime Biotech Recent Developments
  13. 6.3 Synthego
  14. 6.3.1 Synthego Company Information
  15. 6.3.2 Synthego Business Overview
  16. 6.3.3 Synthego Cas12 Nuclease Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Synthego Cas12 Nuclease Product Portfolio
  18. 6.3.5 Synthego Recent Developments
  19. 6.4 Signalchem
  20. 6.4.1 Signalchem Company Information
  21. 6.4.2 Signalchem Business Overview
  22. 6.4.3 Signalchem Cas12 Nuclease Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Signalchem Cas12 Nuclease Product Portfolio
  24. 6.4.5 Signalchem Recent Developments
  25. 6.5 Sigma-Aldrich
  26. 6.5.1 Sigma-Aldrich Company Information
  27. 6.5.2 Sigma-Aldrich Business Overview
  28. 6.5.3 Sigma-Aldrich Cas12 Nuclease Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Sigma-Aldrich Cas12 Nuclease Product Portfolio
  30. 6.5.5 Sigma-Aldrich Recent Developments
  31. 6.6 New England Biolabs
  32. 6.6.1 New England Biolabs Company Information
  33. 6.6.2 New England Biolabs Business Overview
  34. 6.6.3 New England Biolabs Cas12 Nuclease Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 New England Biolabs Cas12 Nuclease Product Portfolio
  36. 6.6.5 New England Biolabs Recent Developments
  37. 6.7 Molecular Cloning Laboratories
  38. 6.7.1 Molecular Cloning Laboratories Company Information
  39. 6.7.2 Molecular Cloning Laboratories Business Overview
  40. 6.7.3 Molecular Cloning Laboratories Cas12 Nuclease Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Molecular Cloning Laboratories Cas12 Nuclease Product Portfolio
  42. 6.7.5 Molecular Cloning Laboratories Recent Developments
  43. 6.8 Integrated DNA Technologies
  44. 6.8.1 Integrated DNA Technologies Company Information
  45. 6.8.2 Integrated DNA Technologies Business Overview
  46. 6.8.3 Integrated DNA Technologies Cas12 Nuclease Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Integrated DNA Technologies Cas12 Nuclease Product Portfolio
  48. 6.8.5 Integrated DNA Technologies Recent Developments
  49. 6.9 Intact Genomics
  50. 6.9.1 Intact Genomics Company Information
  51. 6.9.2 Intact Genomics Business Overview
  52. 6.9.3 Intact Genomics Cas12 Nuclease Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Intact Genomics Cas12 Nuclease Product Portfolio
  54. 6.9.5 Intact Genomics Recent Developments
  55. 6.10 GenScript
  56. 6.10.1 GenScript Company Information
  57. 6.10.2 GenScript Business Overview
  58. 6.10.3 GenScript Cas12 Nuclease Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 GenScript Cas12 Nuclease Product Portfolio
  60. 6.10.5 GenScript Recent Developments
  61. 6.11 Danaher
  62. 6.11.1 Danaher Company Information
  63. 6.11.2 Danaher Business Overview
  64. 6.11.3 Danaher Cas12 Nuclease Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Danaher Cas12 Nuclease Product Portfolio
  66. 6.11.5 Danaher Recent Developments
  67. 6.12 BPS Bioscience
  68. 6.12.1 BPS Bioscience Company Information
  69. 6.12.2 BPS Bioscience Business Overview
  70. 6.12.3 BPS Bioscience Cas12 Nuclease Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 BPS Bioscience Cas12 Nuclease Product Portfolio
  72. 6.12.5 BPS Bioscience Recent Developments
7 North America by Country
  1. 7.1 North America Cas12 Nuclease Sales by Country
  2. 7.1.1 North America Cas12 Nuclease Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Cas12 Nuclease Sales by Country (2021-2026)
  4. 7.1.3 North America Cas12 Nuclease Sales Forecast by Country (2027-2032)
  5. 7.2 North America Cas12 Nuclease Market Size by Country
  6. 7.2.1 North America Cas12 Nuclease Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Cas12 Nuclease Market Size by Country (2021-2026)
  8. 7.2.3 North America Cas12 Nuclease Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Cas12 Nuclease Sales by Country
  2. 8.1.1 Europe Cas12 Nuclease Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Cas12 Nuclease Sales by Country (2021-2026)
  4. 8.1.3 Europe Cas12 Nuclease Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Cas12 Nuclease Market Size by Country
  6. 8.2.1 Europe Cas12 Nuclease Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Cas12 Nuclease Market Size by Country (2021-2026)
  8. 8.2.3 Europe Cas12 Nuclease Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Cas12 Nuclease Sales by Country
  2. 9.1.1 Asia-Pacific Cas12 Nuclease Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Cas12 Nuclease Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Cas12 Nuclease Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Cas12 Nuclease Market Size by Country
  6. 9.2.1 Asia-Pacific Cas12 Nuclease Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Cas12 Nuclease Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Cas12 Nuclease Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Cas12 Nuclease Sales by Country
  2. 10.1.1 South America Cas12 Nuclease Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Cas12 Nuclease Sales by Country (2021-2026)
  4. 10.1.3 South America Cas12 Nuclease Sales Forecast by Country (2027-2032)
  5. 10.2 South America Cas12 Nuclease Market Size by Country
  6. 10.2.1 South America Cas12 Nuclease Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Cas12 Nuclease Market Size by Country (2021-2026)
  8. 10.2.3 South America Cas12 Nuclease Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Cas12 Nuclease Sales by Country
  2. 11.1.1 Middle East and Africa Cas12 Nuclease Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Cas12 Nuclease Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Cas12 Nuclease Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Cas12 Nuclease Market Size by Country
  6. 11.2.1 Middle East and Africa Cas12 Nuclease Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Cas12 Nuclease Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Cas12 Nuclease Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Cas12 Nuclease Value Chain Analysis
  2. 12.1.1 Cas12 Nuclease Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Cas12 Nuclease Production Mode & Process
  7. 12.2 Cas12 Nuclease Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Cas12 Nuclease Distributors
  10. 12.2.3 Cas12 Nuclease Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst